Literature DB >> 436073

Cholestasis associated with d-penicillamine therapy for rheumatoid arthritis.

B D McLeod, T D Kinsella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436073      PMCID: PMC1819252     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  [Intrahepatic cholestasis following treatment with D-penicillamine and indomethacin].

Authors:  H Siegmund
Journal:  Med Welt       Date:  1976-01-23

2.  Treatment of rheumatoid arthritis with penicillamine.

Authors:  H F Hill
Journal:  Semin Arthritis Rheum       Date:  1977-05       Impact factor: 5.532

3.  [Allergic-toxic liver damage due to D-penicillamine].

Authors:  R Rau; S Weber; A Böni
Journal:  Schweiz Med Wochenschr       Date:  1972-08-26

4.  Toxic reactions to penicillamine in patients with Wilson's disease.

Authors:  J M Walshe
Journal:  Postgrad Med J       Date:  1968-10       Impact factor: 2.401

5.  Fatal hepatitis probably due to indomethacin.

Authors:  W M Kelsey; M Scharyj
Journal:  JAMA       Date:  1967-02-20       Impact factor: 56.272

Review 6.  Acetaminophen.

Authors:  B Ameer; D J Greenblatt
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

7.  Toxicity of D-penicillamine in rheumatoid arthritis. A report of 63 patients including two with aplastic anemia and one with the nephrotic syndrome.

Authors:  A S Weiss; J A Markenson; M S Weiss; W H Kammerer
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

8.  Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.

Authors:  Y Shiokawa; Y Horiuchi; M Honma; T Kageyama; T Okada; T Azuma
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

9.  Chronic hepatic inflammation and fibrosis due to low doses of paracetamol.

Authors:  H L Bonkowsky; G H Mudge; R J McMurtry
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.